GlassScriptPhysician profile
Kyle W Abben
NPI 1225321839
$130,213.69
in general payments reported to CMS, 2019-2025
6 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $21K · 2021: $11K · 2022: $27K · 2023: $15K · 2024: $3,605 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $4,887 · Food and Beverage: $2,623 · Education: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,400.00 |
| Travel and Lodging | $4,886.64 |
| Food and Beverage | $2,622.97 |
| Education | $1,250.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $127,622.81 | 2019-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Infinity |
| Gemini Medical LLC | $1,255.00 | 2019-2022 | |
| Foundation Medical, LLC | $1,200.00 | 2022 | |
| Arthrosurface Incorporated | $63.47 | 2019 | |
| Anika Therapeutics, INC. | $50.66 | 2021 | |
| Integra Lifesciences Corporation | $21.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Abben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.